SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025316
Filing Date
2019-05-10
Accepted
2019-05-10 17:02:27
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv520511_10q.htm 10-Q 347219
2 EXHIBIT 10.3 tv520511_ex10-3.htm EX-10.3 96419
3 EXHIBIT 31.1 tv520511_ex31-1.htm EX-31.1 10474
4 EXHIBIT 31.2 tv520511_ex31-2.htm EX-31.2 10467
5 EXHIBIT 32.1 tv520511_ex32-1.htm EX-32.1 3958
6 EXHIBIT 32.2 tv520511_ex32-2.htm EX-32.2 3667
13 GRAPHIC tv520511_img01.jpg GRAPHIC 20105
14 GRAPHIC tv520511_img02.jpg GRAPHIC 177532
  Complete submission text file 0001144204-19-025316.txt   4634808

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mrkr-20190331.xml EX-101.INS 1320284
8 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20190331.xsd EX-101.SCH 36924
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20190331_cal.xml EX-101.CAL 27331
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20190331_def.xml EX-101.DEF 178307
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20190331_lab.xml EX-101.LAB 225825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20190331_pre.xml EX-101.PRE 216629
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 19815836
SIC: 2834 Pharmaceutical Preparations